205 related articles for article (PubMed ID: 9119029)
1. Overexpression of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, is associated with enhanced metacyclogenesis.
Tomas AM; Miles MA; Kelly JM
Eur J Biochem; 1997 Mar; 244(2):596-603. PubMed ID: 9119029
[TBL] [Abstract][Full Text] [Related]
2. Effects of proteinase inhibitors on the growth and differentiation of Trypanosoma cruzi.
Franke de Cazzulo BM; Martínez J; North MJ; Coombs GH; Cazzulo JJ
FEMS Microbiol Lett; 1994 Nov; 124(1):81-6. PubMed ID: 8001773
[TBL] [Abstract][Full Text] [Related]
3. Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion.
Ferrão PM; d'Avila-Levy CM; Araujo-Jorge TC; Degrave WM; Gonçalves Ada S; Garzoni LR; Lima AP; Feige JJ; Bailly S; Mendonça-Lima L; Waghabi MC
PLoS One; 2015; 10(5):e0124832. PubMed ID: 25938232
[TBL] [Abstract][Full Text] [Related]
4. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
Lalmanach G; Mayer R; Serveau C; Scharfstein J; Gauthier F
Biochem J; 1996 Sep; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
[TBL] [Abstract][Full Text] [Related]
5. Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells.
Santos CC; Sant'anna C; Terres A; Cunha-e-Silva NL; Scharfstein J; de A Lima AP
J Cell Sci; 2005 Mar; 118(Pt 5):901-15. PubMed ID: 15713748
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of cruzipain and a cathepsin B-like target in a Trypanosoma cruzi cell line displaying resistance to synthetic inhibitors of cysteine-proteinases.
Yong V; Schmitz V; Vannier-Santos MA; de Lima AP; Lalmanach G; Juliano L; Gauthier F; Scharfstein J
Mol Biochem Parasitol; 2000 Jun; 109(1):47-59. PubMed ID: 10924756
[TBL] [Abstract][Full Text] [Related]
7. Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.
Lima AP; dos Reis FC; Serveau C; Lalmanach G; Juliano L; Ménard R; Vernet T; Thomas DY; Storer AC; Scharfstein J
Mol Biochem Parasitol; 2001 Apr; 114(1):41-52. PubMed ID: 11356512
[TBL] [Abstract][Full Text] [Related]
8. Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi.
Monteiro AC; Abrahamson M; Lima AP; Vannier-Santos MA; Scharfstein J
J Cell Sci; 2001 Nov; 114(Pt 21):3933-42. PubMed ID: 11719560
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro.
Meirelles MN; Juliano L; Carmona E; Silva SG; Costa EM; Murta AC; Scharfstein J
Mol Biochem Parasitol; 1992 Jun; 52(2):175-84. PubMed ID: 1620157
[TBL] [Abstract][Full Text] [Related]
10. Induction of autophagy increases the proteolytic activity of reservosomes during
Losinno AD; Martínez SJ; Labriola CA; Carrillo C; Romano PS
Autophagy; 2021 Feb; 17(2):439-456. PubMed ID: 31983275
[TBL] [Abstract][Full Text] [Related]
11. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
12. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes.
Aparicio IM; Scharfstein J; Lima AP
Infect Immun; 2004 Oct; 72(10):5892-902. PubMed ID: 15385491
[TBL] [Abstract][Full Text] [Related]
13. A fragment of the major histocompatibility complex class II-associated p41 invariant chain inhibits cruzipain, the major cysteine proteinase from Trypanosoma cruzi.
Bevec T; Stoka V; Pungercic G; Cazzulo JJ; Turk V
FEBS Lett; 1997 Jan; 401(2-3):259-61. PubMed ID: 9013899
[TBL] [Abstract][Full Text] [Related]
14. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
15. Discrimination of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, and mammalian cathepsins B and L, by a pH-inducible fluorogenic substrate of trypanosomal cysteine proteinases.
Serveau C; Lalmanach G; Hirata I; Scharfstein J; Juliano MA; Gauthier F
Eur J Biochem; 1999 Jan; 259(1-2):275-80. PubMed ID: 9914503
[TBL] [Abstract][Full Text] [Related]
16. [Cruzipain, major cysteine proteinase of Trypanosoma cruzi: sequence and genomic organization of the codifying genes].
Cazzulo JJ
Medicina (B Aires); 1999; 59 Suppl 2():7-10. PubMed ID: 10668237
[TBL] [Abstract][Full Text] [Related]
17. Redirection of the immune response to the functional catalytic domain of the cystein proteinase cruzipain improves protective immunity against Trypanosoma cruzi infection.
Cazorla SI; Frank FM; Becker PD; Arnaiz M; Mirkin GA; Corral RS; Guzmán CA; Malchiodi EL
J Infect Dis; 2010 Jul; 202(1):136-44. PubMed ID: 20497050
[TBL] [Abstract][Full Text] [Related]
18. Stage-regulated expression of cruzipain, the major cysteine protease of Trypanosoma cruzi is independent of the level of RNA1.
Tomás AM; Kelly JM
Mol Biochem Parasitol; 1996; 76(1-2):91-103. PubMed ID: 8919998
[TBL] [Abstract][Full Text] [Related]
19. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is antigenic in human infections.
Martinez J; Campetella O; Frasch AC; Cazzulo JJ
Infect Immun; 1991 Nov; 59(11):4275-7. PubMed ID: 1937786
[TBL] [Abstract][Full Text] [Related]
20. The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites.
Santos VC; Oliveira AER; Campos ACB; Reis-Cunha JL; Bartholomeu DC; Teixeira SMR; Lima APCA; Ferreira RS
Sci Rep; 2021 Sep; 11(1):18231. PubMed ID: 34521898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
